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Coronaviruses (CoVs) are enveloped viruses containing a single-stranded, positive-sense RNA genome of approximately 27--32 kb \[[@CR1]\]. Currently, CoVs are grouped under four distinct genera: *Alphacoronavirus*, *Betacoronavirus*, *Gammacoronavirus*, and *Deltacoronavirus* \[[@CR2], [@CR3]\].

Bat species have been recognized as major reservoirs of several emerging infectious diseases, such as severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) \[[@CR4]--[@CR6]\]. SARS is caused by a member of the *Betacoronavirus* genus and is the first global pandemic disease that has emerged in the Guangdong Province of China in 2002. SARS has spread to 25 countries across five continents, infecting 8096 people worldwide with a 9.5% (774/8096) fatality \[[@CR7]--[@CR9]\].

The four structural proteins (S, E, M, and N) are essential for viral entry and assembly. The S gene is the most important structural protein. The receptor-binding motif (RBM) within the receptor-binding domain (RBD) located in the S gene determines host tropism by binding angiotensin-converting enzyme 2 (ACE2) receptor \[[@CR10], [@CR11]\]. The RBD has two critical residues (N479 and T487) that play key roles in ACE2 receptor recognition and binding associated with human transmission \[[@CR7], [@CR12]\].

Novel coronaviruses are continuously being discovered in bat species around the world, especially in China \[[@CR7], [@CR13]\]. Due to relatively close geographic locations of bat species between China and the Republic of Korea, the surveillance of CoV prevalence and the analysis of their genetic information may be crucial for preventing a future outbreak \[[@CR14]\]. However, there have been few investigations into SARS-related bat Beta-CoV prevalence \[[@CR4]\]. In addition, whole genome analysis of SARS-related bat Beta-CoV has not yet been carried out in the Republic of Korea.

Together with the fact that bats are reservoirs of CoVs, genetic information about these CoVs may provide valuable information regarding the possible risk of these viruses infecting humans. In the present study, the complete genome sequence of SARS-related Beta-CoV (16BO133) isolated from *Rhinolophus ferrumequinum* was first characterized. The genome of 16BO133 was then compared with that of reference CoVs to demonstrate genetic diversity and a potential genetic feature associated with host tropism.

Results and discussion {#Sec2}
======================

An oral swab was collected from bats living in their natural habitat in 2016. Bats were captured using a net for collection of oral swabs and were released immediately after sampling. Oral swab samples were kept in a viral transport medium at 4 °C. The oral swab sample was suspended in 1% antibiotic--antimycotic solution (Corning, USA) diluted in phosphate-buffered saline (PBS), and clarified by centrifugation at 3500×*g* for 10 min. RNA from the 200 μL sample was extracted with the QIAamp^®^ Viral RNA mini kit (Qiagen, Germany) and eluted in 60 μL RNase-free water. cDNA was synthesized using a PrimeScript First Strand cDNA Synthesis kit (Takara, Japan) according to the manufacturer's instructions. Bat-CoV screening was performed by a pancoronavirus PCR method based on primers as follows: (Corona forward, 5′-GGTTGGGACTATCCTAAGTGTGA-3′ and Corona reverse, 5′-CCATCATCAGATAG AATCATCATA-3′). The pancoronavirus primers were used to amplify and sequence a 440-bp segment of the highly conserved RNA-dependent RNA polymerase (RdRp) gene. Fifty-nine pairs of primers were synthesized by the Genotech corporation (Daejeon, Korea) and PCR was performed using an ABI 9800 GeneAmp system (Applied Biosystems, Foster City, CA, USA). The products were purified using a QIAquick gel extraction kit (Qiagen, Germany) according to the manufacturer's instructions. The purified PCR products were sequenced using the BigDye^®^ Terminator Cycle Sequencing kit version 1.1 (Applied Biosystems, Foster City, CA, USA) and an ABI 3730 DNA sequencer (Applied Biosystems, Foster City, CA, USA). Whole genome sequences were submitted to GenBank (accession number KY938558). The nucleotide and amino acid sequences were aligned and compared to CoV sequences available from the GenBank database using ClustalW software implemented in BioEdit version 7.0.9.0. The phylogenetic trees were drawn using the neighboring joining method using the maximum composite likelihood model with MEGA 7 software. The bootstrap values were calculated with 1000 replicates.

The amino acid sequences of ORF 1ab and spike gene were analyzed for phylogenetic characterization. 16BO133 was grouped with the SARS-related Beta-CoV lineage B, not only due to sequence similarity with ORF 1ab but also with the spike gene (Fig. [1](#Fig1){ref-type="fig"}). The RF 1ab and spike amino acids were closely related to JTMC15. However, 16BO133 was distinctly located in the phylogenetic topology of the human SARS CoV strain (Tor2, Urbani, Frankfurt1, and ShanghaiQXC1).Fig. 1Phylogenetic analysis using whole genome sequences of ORF 1ab with reference strains. The phylogenetic trees were drawn using the neighboring joining method using the maximum composite likelihood model with MEGA 7 software. The bootstrap values were calculated with 1000 replicates. Phylogenetic analysis using whole genome sequences of the spike region with reference strains. The phylogenetic trees were drawn using the neighboring joining method using the maximum composite likelihood model with MEGA 7 software. The bootstrap values were calculated with 1000 replicates

The whole genomic sequence of 16BO133 was 29,075 nt in length with G+C contents of 40.9%. As shown in Table [1](#Tab1){ref-type="table"}, 16BO133 has a similar genome organization to other SARS-related Beta-CoVs, such as JTMC15, Rf1, and Tor2. The 16BO133 showed a high amino acid identity ranging from 93.8% to 100% with JTMC15. However, it showed considerably lower nucleotide identity ranging from 75.2 to 99.5% with Rf1 and Tor2 (Table [1](#Tab1){ref-type="table"}). In addition, a complete deletion of amino acids was observed in the ORF8 region, which is similar to JTMC15 (Table [1](#Tab1){ref-type="table"}). The spike gene nucleotides of 16BO133 showed extensive variations compared to other SARS-related bat Beta-CoV (Rf1) and human SARS CoV (Tor2), thereby resulting in a low amino acid identity. Amino acid identities of 16BO133 spike region with Rf1 and Tor2 were 84.7% and 75.2%, respectively (Table [1](#Tab1){ref-type="table"}).Table 1Comparison of ORF amino acid identities of 16BO133 and other SARS-CoVsORF16BO133JTMC15Rf1Tor2LengthLength% IdentityLength% IdentityLength% Identity1a4184418499.3437798.2437793.41b2646264699.5262898.2264198.1S1236123699.4124184.7125575.23a27027498.527497.0274 (ORF3)^a^85.23b11411499.111496.5154 (ORF4)^a^89.5E767697.47697.47698.7M22122199.522199.522197.36636398.46398.463 (ORF7)^a^92.17a12212297.512295.9122 (ORF8)^a^89.37b485293.754497.744 (ORF9)^a^93.28------122--39 (ORF10)^a^--N42042099.342197.142294.39a979795.99794.898 (ORF13)^a^75.39b70701007094.370 (ORF14)^a^84.3Abbreviation and accession numbers: JTMC15, KU182964; Rf1, DQ412042; Tor2, AY274119^a^ORF 3a, 3b, 6, 7a, 7b, 8, 9a, and 9b are described as ORF 3, 4, 7, 8, 9, 10, 13, and 14 in Tor2

As shown in Supplementary Fig. 1, the RBM (aa 426--518) located in the S protein showed 18 amino acid deletions (aa 433--437 and 457--469) including critical residues, N479S and T487V. The regions corresponding to TGNYN (433--437) and NVPFSPDGKPCTP (457--469) in human SARS CoV (Tor2) were identified as the major deletion sites in 16BO133. In addition, the insertion of the two nucleotides (cytosine and threonine) was observed in front of the stop codon of ORF7b in 16BO133 (Supplementary Fig. 2). This feature induces a frame shift of the stop codon, resulting in the complete elimination of ORF8.

The bats discovered in the Republic of Korea are considered to be insectivores, and 23 species were reported to exist in this region in a previous study \[[@CR4]\]. Recently, wildlife and human contact has increased due to the rapid urbanization. People think that bats are not dangerous because they either living in caves or in abandoned mines. In the present study, SARS-related bat Beta-CoV was identified from *R. ferrumequinum* in an abandoned mine at the Jeonbuk province. Recently, some people visited the abandoned mine out of curiosity, not realizing the risk of exposure to CoV infections upon contact with bat carriers. Therefore, people should keep in mind that bats can spread diseases to humans and should refrain from visiting abandoned mines.

The S gene associated with the spike protein is divided into S1 and S2 domains \[[@CR15]--[@CR17]\]. The S gene is composed of distinct N-terminal (S1) and conserved C-terminal (S2) domains. The S1 domain is prone to have high mutation rates as the virus evolves because it is the major antigenic factor. Therefore, it is thought to be the main reason that the spike protein of 16BO133 has the lowest amino acid identity (75.2%) compared to human SARS CoV (Tor2) within various ORFs.

The S1 domain contains a receptor-binding domain (RBD), which mediates receptor binding of the virus to host cells and determines the host spectrum. The RBM (aa 426 to 518) within the RBD (aa 319 to 518) is the most important motif for recognizing the host receptor, human angiotensin-converting enzyme 2 (ACE2), and it is a major antigenic determinant required to elicit the production of neutralizing antibodies. The RBM has two critical residues, N479 and T487, which play key roles in receptor recognition and binding \[[@CR15]\]. The substitution of these two critical residues can completely eliminate viral binding to the human ACE2 receptor \[[@CR12]\]. However,  substitution of ether residue alone has no significant impact on human ACE2 binding \[[@CR18]\].  In the present study, the S gene of 16BO133 (1236 aa) showed a difference of 19 amino acids when compared to SARS CoV (Tor2, 1255 aa) due to 5 aa insertions and 24 aa deletions. Of the 24 aa deletions, 75% (18/24) were located in the RBD. In conclusion, it is thought that 16BO133 may have very low possibility to human infection due to the mutation of two critical residues (N479S and T487V), two major deletion sites (433--437, 457--469) in the RBD and low amino acid identity (75.2%) of S gene with SARS CoV Tor2.

According to previous reports \[[@CR4]\], B15-21 bat CoV was identified from *R. ferrumequinum* and firstly reported in Republic of Korea. The B15-21 was clustered with the *Betacoronavirus* and grouped with SARS-like bat CoV found in China. The receptor-binding domain (RBD) of B15-21 had two major deletion sites, TGNYN and PFSPDGKPCTPPA, compared to human SARS CoV Tor2. The 16BO133 also had two major deletion sites in RBD, TGNYN (433--437) and NVPFSPDGKPCTP (457--469), compared to human SARS CoV Tor2. The amino acid differences between B15-21 (PFSPDGKPCTPPA) and 16BO133 (NVPFSPDGKPCTP) are evolving evidence of SARS-like bat CoV in Republic of Korea.

The ORF8 region located upstream of the N gene is known to be a "high mutation region" from previous reports \[[@CR3], [@CR19]\]. Most human SARS CoVs during epidemic had undergone 29 nucleotides deletion in ORF8 compared to civet SARS CoV, suggesting that this region may be important for interspecies transmission \[[@CR20]\]. In the present study, a complete deletion of amino acids was observed in the ORF8 region of 16BO133. Interestingly, insertion of two nucleotides (cytosine and threonine) was observed in front of the stop codon of ORF7b. The insertion of two nucleotides induced an ORF frame shift resulting in addition of four amino acids of ORF7b and an elimination of the start codon of ORF8. Further studies are needed on how these changes will influence SARS-like bat CoV.

According to previous reports, SARS-like bat CoV (RP3) was first discovered in China \[[@CR19]\]. The overall sequence identity between RP3 and human SARS CoV Tor2 was 92%. However, the S1 domain of the S protein showed 64% sequence identity due to amino acid deletions. After the discovery of RP3, two novel SARS-like bat CoVs (Rs3367 and LYRa11) have been described, which are more closely related to human SARS CoV Tor2 \[[@CR7], [@CR20]\]. Rs3367 and LYRa11 have high amino acid identities of 89.6% to 89.9%, respectively, with human SARS CoV Tor2, particularly in the RBM region without amino acid deletion. The evolution of the CoV can lead to a novel CoV that is highly contagious in humans, which can lead to a serious problem.

In conclusion, the CoV can possibly be transmitted to human populations due to CoV mutations occurring as a result of high mutation rates as the virus evolves. Therefore, continuous monitoring and genomic sequence characterization of the SARS-like bat CoV should be performed to prevent human infections that may result from genetic variation.

Electronic supplementary material
=================================

 {#Sec3}

Below is the link to the electronic supplementary material. Supplemental Fig. 1. The comparison of amino acids between SARS-like bat CoVs and human SARS CoV in the receptor-binding motif (RBM). Major deletion sites are marked in gray color. The two critical residues (N479 and T487) that play key roles in human ACE2 receptor recognition and binding are marked in asterisks. Supplemental Fig. 2. The comparison of amino acid sequences between ORF7b and ORF8 regions. Insertion of the two nucleotides (cytosine and threonine) is marked by a blue rectangle. The stop codons of ORF7b are marked by red rectangles. The start codon of ORF8 is marked by a black circle above the nucleotide ATG letters. Supplementary material 1 (PPTX 104 kb)
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